Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-827-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 199-06-01 to 1999-06-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline and GLP conform well documented scientific study report.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium, other: TA 97a, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- The genotypes of the tested strains were checked at each study:
Histidine auxotrophy, ampicillin resistance, tetracycline resistance, UV-sensitivity and growth inhibition by crystal violet. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- metabolic activation system: (S9) fraction from livers of Wistar male rats, which were induced with Phenobarbital intraperitoneal and beta-Naphtoflavone orally.
- Test concentrations with justification for top dose:
- 1. Study (+/- S9):
All strains: 0.005, 0.05, 0.5 (mg/plate)
Based on the reults of the 1. study concentrations of the second study were selected.
2. Study (+/- S9):
TA97a, TA98, TA 100: 0.5, 0.16, 0.5, 1.6, 5 (mg/plate)
TA102: 0.016, 0.05, 0.16, 0.5, 1.6 (mg/plate)
3. Study:
TA102 (- S9): 0.5, 1.6, 5 (mg/plate)
TA102 (+ S9): 5 (mg/plate) - Vehicle / solvent:
- Dimethy sulfoxide (DMSO)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cumene hydroperoxide
- other: ICR 191; 4-Nitro-o-phenylen-diamine; Nitrofurantoine; 2-Aminoanthracen, Danthron
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
First study was conducted with 3 concentration levels of the test substance from 0.005 – 0.5 mg/plate in geometrical series of factor 10.
Based on the results of the first study concentrations in a logarithmic series with a factor of √ 10 were tested in the second and third study as specified. Plates for confirmation of genotypes were incubated for 24 h and plates of mutagenicity test for 48 h, respectively, at 37 ± 1 °C. Genotypes were evaluated for each study.
Plates of the mutagenicity test were inspected for present and reduced background lawn after an incubation time of 48 h, respectively. Colonies per plate (revertants) were counted if no reduced background lawn was observed. - Evaluation criteria:
- Evaluation:
Since the reduced background lawn is regarded to be a cytotoxic effect, plates with reduced background lawn were not included into evaluation procedures. Arithmetic mean values and standard deviations were calculated out of colonies per plate of three replicates.
The test substance is to be interpreted mutagenic if there is a concentration effect relationship and the induction rate is ≥2.
Validity criteria:
Spontaneous revertants (negative controls) had to be within the following ranges:
- TA 97a ± S9: 60- 300 revertants/plate
- TA98 ±S9: 15- 50 revertants/plate
- TA 100 ± S9: 60 - 200 revertants/plate
- TA 102 ± S9: 240 - 460 revertants/plate
The induction rates of the positive controls had to be ≥2 - Species / strain:
- other: TA 97a, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Based on the results of this test, the test substance is regarded to be not mutagenic. - Executive summary:
In order to assess the mutagenic effects of the test substance it were determined in a reverse mutation assay according to OECD test guideline 471 in three independent studies. The test system were the Salmonella typhimurium strains TA97a, TA 98, TA100 and TA102 with and without metabolic activation system S9. Positive and negative controls were included in each study. Duration of each study was 48 hours. The test substance was applied once at test intitiation for the 1. study for all strains at the concentrations (with and without S9) of 0.005, 0.05 and 0.5 (mg/plate) dissolved in vehicle DMSO. Based on the results of the 1. study, concentrations of 0.5., 0.16, 0.5 and 5 mg/plate (with and wihtout S9) were selected for the second study for strains TA97a, TA98 and TA 100. For the strain TA102 concentrations of 0.016, 0.05, 0.16, 0.5, 1.6 (mg/plate) with and without S9 were selected. For the third study the strain TA102 was tested without S9 at concentrations of 0.5, 1.6 and 5 (mg/plate) and with S9 at concentration of 5 mg/plate. The validity of the test system was approved with sufficient positive controls.
Based on the results of this test the test substance is regarded to be not mutagenic.
Reference
Table 1: Summary of Mutagenic and cytotoxic effects of test substance
S. typhimurium strain |
S9 |
Tested concentration [mg/plate] |
Lowest mutagenic concentration[mg/plate] |
Lowest cytotoxic concentration[mg/plate] |
TA97a |
— |
0.005 - 5.0 |
none |
5 |
+ |
0.005 - 5.0 |
none |
none |
|
TA98 |
— |
0.005 - 5.0 |
none |
none |
+ |
0.005 - 5.0 |
none |
none |
|
TA100 |
— |
0.005 - 5.0 |
none |
5 |
+ |
0.005 - 5.0 |
none |
none |
|
TA102 |
— |
0.005 - 5.0 |
none |
none |
+ |
0.005 - 5.0 |
none |
none |
Table 2: Mutagenicity test (1. Study)
|
No. Revertants (mean of 3 plates) |
||||||||
Concentration |
TA97a |
TA98 |
TA100 |
TA102 |
|||||
[mg/plate] |
- S9 |
+ S9 |
- S9 |
+ S9 |
- S9 |
+ S9 |
- S9 |
+ S9 |
|
Negative Control |
189 |
226 |
22 |
23 |
100 |
88 |
379 |
418 |
|
Test substance |
0.5 |
158 |
141 |
13 |
27 |
71 |
87 |
cytotoxic |
390 |
0.05 |
208 |
175 |
18 |
20 |
99 |
76 |
349 |
401 |
|
0.005 |
172 |
193 |
19 |
23 |
102 |
79 |
349 |
364 |
Table 3: Mutagenicity test (2. Study)
|
No. Revertants (mean of 3 plates) |
||||||||
Concentration |
TA97a |
TA98 |
TA100 |
TA102 |
|||||
[mg/plate] |
- S9 |
+ S9 |
- S9 |
+ S9 |
- S9 |
+ S9 |
- S9 |
+ S9 |
|
Negative Control |
196 |
204 |
18 |
16 |
177 |
131 |
365 |
335 |
|
Test substance |
5.0 |
cytotoxic |
144 |
13 |
10 |
cytotoxic |
115 |
317 |
405 |
1.6 |
126 |
170 |
9 |
10 |
94 |
96 |
302 |
450 |
|
0.5 |
181 |
201 |
15 |
18 |
111 |
125 |
298 |
415 |
|
0.16 |
198 |
208 |
13 |
29 |
145 |
104 |
392 |
404 |
|
0.05 |
179 |
177 |
18 |
19 |
154 |
111 |
424 |
443 |
Table 4: Mutagenicity test (3. Study)
|
No. Revertants (mean of 3 plates) |
||
Concentration |
TA102 |
||
[mg/plate] |
- S9 |
+ S9 |
|
Negative Control |
330 |
339 |
|
Test substance |
5 |
225 |
293 |
1.6 |
309 |
Nt |
|
0.5 |
311 |
Nt |
Nt = Not tested
Table 5: Induction rates of positive controls
strain |
Reference substance |
(µg/plate) |
(S9) |
Induction rate/study |
||
1. |
2. |
3. |
||||
TA 97a |
ICR 191 acridine mutagen dihydrochloride |
0.5 |
— |
>5.3 |
>5.1 |
Nt |
2-Aminoanthracene |
2.0 |
+ |
>4.4 |
>4.9 |
Nt |
|
TA 98 |
4-nitro-1,2-phenylenediamine |
0.5 |
— |
3.2 |
5.5 |
Nt |
2-Aminoanthracene |
2.0 |
+ |
>43.5 |
>62.5 |
Nt |
|
TA 100 |
Nitrofrantoine |
0.2 |
— |
4.4 |
2.7 |
Nt |
2-Aminoanthracene |
2.0 |
+ |
11.3 |
>7.7 |
Nt |
|
TA 102 |
Cumene hydroperoxide |
100 |
— |
>2.6 |
>2.7 |
>3.0 |
Danthron |
30 |
+ |
>2.4 |
>3.0 |
>3.0 |
Nt = Not tested
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The mutagenic effects of the test item were determined in a reverse mutation assay with Salmonella typhimurium. Test systems were the strains TA97a, TA 98, TA 100 and TA 102 with (+) and without (-) the metabolic activation system S9 (from male Wistar rats). Concentrations tested were 0.005 - 0.05 - 0.16 - 0.5 - 1.6 and 5 mg/plate. Three replicates per concentration level and control were performed. Based on the results of this study the test item was found to have no mutagenic effects on Salmonella typhimurium strains TA 97a, TA 100, TA 98, and TA 102 with (+) and without (-) the metabolic activation system S9 from Wistar rats at concentrations up to 5 mg/plate.
In order to study the induction of micronuclei in bone marrow cells Hostacor 4323 was tested in an in vivo micronucleus test in erythrocytes according to OECD 474 guideline performed in NMRI mice. The test substance was administered to ten mice (5/ sex) twice at an interval of 24 hours orally by gavage to the test animals at a dose of 2000 mg/kg bw. The vehicle, sesame oil, was administered in the same way to the negative control groups. Cyclophosphamide was used as positive substance and was administered once orally at a dose of 50 mg/kg bw.The number of polychromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic erythrocytes to total erythrocytes in both male and female animals remained unaffected by the treatment with Hostacor 4323. Cyclophosphamide induced a marked statistically significant increase in the number of polychromatic cells with micronuclei, indicating the sensitivity of the test system.
Justification for classification or non-classification
Based on the available data no classification is warranted according to the criteria laid down in the EU Dangerous Substances Directive (67/548/EEC) and in the EU Classification Labelling and Packaging Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.